Medical Devices

In December 2024, China’s NMPA issued a notice regarding adjustments to the classification codes for in Vitro diagnostic reagents.|In December 2024, China’s NMPA issued a notice regarding adjustments to the classification codes for in Vitro diagnostic reagents.

On January 10, 2025, the NMPA released Chinese medical device regulatory data for 2024. This publication, which reflects data up to Dec...|On January 10, 2025, the NMPA released Chinese medical device regulatory data for 2024. This publication, which reflects data up to Dec...

One of the primary objectives of China's centralized procurement mechanism is ensuring that the medicines and medical consumables...|One of the primary objectives of China's centralized procurement mechanism is ensuring that the medicines and medical consumables...

The national standard "Diagnostic Techniques for Equine Rhinopneumonitis" has been published and is set to be implemented on June 1, 2025.|The national standard "Diagnostic Techniques for Equine Rhinopneumonitis" has been published and is set to be implemented on June 1, 2025.

The national standard titled "Diagnostic Techniques for Canine Distemper" has been published and is set to come into effect on June 1, 2025.|The national standard titled "Diagnostic Techniques for Canine Distemper" has been published and is set to come into effect on June 1, 2025.

On October 21, 2024, the NMPA of China provided an overview of the current status of pediatric IVD reagents in the country, highlighting...|On October 21, 2024, the NMPA of China provided an overview of the current status of pediatric IVD reagents in the country, highlighting...

The NMPA has released a draft of the ‘Good Manufacturing Practices for Medical Devices’, which is now open for public comment...|The NMPA has released a draft of the ‘Good Manufacturing Practices for Medical Devices’, which is now open for public comment...

2024 IVD Reagents Clinical Trial Exemption Catalog draft has been announced by the CMDE on November 4, 2024, and opened for public consultation|2024 IVD Reagents Clinical Trial Exemption Catalog draft has been announced by the CMDE on November 4, 2024, and opened for public consultation

China domestic production of imported medical devices policy has been drafted and released by the National Medical Products Administration (NMPA) on November 4 ,2024.|China domestic production of imported medical devices policy has been drafted and released by the National Medical Products Administration (NMPA) on November 4 ,2024.

China medical device industry standards were issued by the National Medical Products Administration in July 2024.|China medical device industry standards were issued by the National Medical Products Administration in July 2024.

GBA Connect Scheme has approved 79 medical products—39 pharmaceuticals and 40 devices—benefiting ~10,000 GBA patients as of October 9, 2024.

Hong Kong 2024 Policy Address: Key regulatory updates on medical product approvals and initiatives to enhance biomedical research.